WCM-Q Grand Rounds

---

RSSWEBINARDHPAMA

Occurs every 2 weeks on Sunday starting on 1/9/2022 at 3:30 PM
Sunday, January 9, 2022, 3:30 PM - 4:30 PM, Livestream (Zoom)

WCM-Q Grand Rounds is a lecture series with the aim of providing physicians and other healthcare practitioners updates on current issues related to healthcare. Grand Rounds have been long an integral part of the education of physicians and this series will be delivered in a format that promotes presenter/audience interactions. The series will not focus on any one area speciality but offer an array of multidisciplinary topics. WCM-Q Grand Rounds will be held twice per month. Each lecture will be maximum of one hour in length , including 15 mins for a question and answer period. Participants will benefit from the opportunity to discuss topics that can help in the improvement of patient care.

1. 1- Identify key factors and challenges in addressing a variety of health needs generally and also apply them to the local cultural expectations
2. 2- Discuss the impact this expanded knowledge has on their ability to diagnose or assess the patient
3. 3- Identify the benefits the gained knowledge has on developing a multidisciplinary approach to patient care

No Registration Fee

Scientific Planning Committee: Tariq Chukir, MD, Thurayya Arayssi, MD, Sohaila Cheema, MBBS, Deema Al-Sheikhly, MRes, MEPH, Sheila Qureshi, PhD, Christopher Triggle, PhD, Maria Paiva, PharmD, Andrew Jones, BSN, Phyllis Sui Muffuh Navti, Doctorate in Pharmacy Practice, Reshma Bholah, MD, Constatina Dalassou, DDS, Devin Thompson, RT, have no relevant financial relationship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Jamie M. Gray, MLS, MS has disclosed the following relationships:Stock Shareholder - Proctor & Gamble;Colgate-Palmolive and WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Faculty: Sadeer Al-Kindi, MD, Duncan Hau, MD, Richard Bockman, MD, Jane Jeffrie Seley, DNP, Courtney Peterson, PhD, Nir Barzilai, MD, Mohamad Alkadi, MD, Diego Real de Asua, MD, PhD, Subhi J. Al'Aref, MD, Abdallah Mahrous, MD, Abdulrahman Arabi, MD F.A.C.C, Jad Sfeir, MD, Essa A Abuhelaiqa, MD, Tania Jaber, MD, Caitlin Huckell, MD, Laith Abu-Raddad, PhD, Aicha Hind Rifai, MD, Gary L Beck Dallaghan, PhD, Caren Solomon, MD, MPH, Sara Saleh Al-Khawaga, MD, PhD, have no relevant financial relationship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products. 

Jamie M. Gray, MLS, MS has disclosed the following relationships:Stock Shareholder - Proctor & Gamble;Colgate-Palmolive and WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Mohamud A. Verjee, MD, MBA, has disclosed the following relationship: Consultant - Hoff man La Roche and WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Azeez Farooki, MD, has disclosed the following relationship: Consultant - Novartis and WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Julia W. Tripple, MD, has disclosed the following relationship: Honorarium Recipient - SANOFI and WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Adam Tenforde, MD has disclosed the following relationships: Consultant - StateFarm; Grant/Research Support Recipient - Enovis; Grant/Research Support Recipient -DOD; Consultant - Strava and WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Marcus D. Goncalves, MD, PhD, has disclosed the following relationships: Consultant - Scorpion Therapeutics;Novartis AG
Owner - Faeth Therapeutics ; Board Member, Advisory Committee Member /Review Panel Member - Pfizer and WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Emad Mansoor, MD has disclosed the following relationships:and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Grants/ Research Support Recipient  - 

National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University Hospitals Research and Education Institute 
Lansing C. Hoskins Education and Research Fund Grant by the Case Western Reserve University School of Medicine 

Mohsen Eledrisi, MD, FACP, FACE, has disclosed the following relationships: 
Honorarium Recipient - Boehringer; Merck and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Administrative Contacts: Asha Fernandes, Safia Rabia, have no relevant financial relationship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

ICR: Tariq Chukir, MD, has no relevant financial relationship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.